AIP
DERM icon

Ameritas Investment Partners’s Journey Medical DERM Stock Holding History

Ameritas Investment Partners’s Portfolio DERM Stock Details DERM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.81K Hold
1,239
– – ﹤0.01% 2969
2025
Q4 		$9.55K Hold
1,239
– – ﹤0.01% 2922
2025
Q3 		$8.82K Hold
1,239
– – ﹤0.01% 2973
2025
Q2 		$8.9K Buy
+1,239
New +$8.56K ﹤0.01% 3012

Other funds holding DERM

WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
JGC
J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return
PFCS
Pale Fire Capital SE Prague, Czech Republic $1.14B AUM 42.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Ameritas Investment Partners's DERM Position: Q1 2026 in Review

Ameritas Investment Partners held its Journey Medical (DERM) position steady in Q1 2026 at 1,239 shares worth $5.81K. The position accounts for ﹤0.01% of the portfolio, ranked #2969.

Ameritas Investment Partners first reported a position in DERM in Q2 2025 and has held it in 4 quarters since. The position peaked at $9.55K in Q4 2025. 71 funds tracked by Wall St. Rank hold DERM as of Q1 2026.

  • Ameritas Investment Partners held 1,239 shares of Journey Medical worth $5.81K as of Q1 2026.
  • Ameritas Investment Partners left its Journey Medical share count unchanged in Q1 2026.
  • Journey Medical made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2969 holding.
  • Ameritas Investment Partners first reported a position in Journey Medical in Q2 2025 and has held it in 4 quarters since.
  • Ameritas Investment Partners's Journey Medical position peaked at $9.55K in Q4 2025.
  • 71 funds tracked by Wall St. Rank held Journey Medical as of Q1 2026.

Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.